Where does China Medical University Hospital rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), China Medical University Hospital ranks #15,899 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does China Medical University Hospital hold?

China Medical University Hospital holds 18 US utility patents granted between 2017 and 2025, spanning 16 technology areas.

What is China Medical University Hospital's Innovation Score?

China Medical University Hospital has an Innovation Score of 41.3 out of 100 (top 34% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does China Medical University Hospital focus on?

China Medical University Hospital's top technology area is C07K (Peptides) with 8 patents, ranking #1,078 of 3,615 assignees active in that subclass. Grants appear in 16 CPC subclasses total.

Is China Medical University Hospital's patent grant rate increasing or decreasing?

China Medical University Hospital's recent grant velocity is +300% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for China Medical University Hospital's patents?

China Medical University Hospital's patents average 10.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the China Medical University Hospital patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

China Medical University Hospital

USPTO PatentsView assignee record - 18 granted patents across 16 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, China ranks #15,899 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 16 technology areas.

#15,899
of 49,997 US assignees by volume: Top 34%
by Innovation Score (41.3/100): 10.4
avg claims per patent: +300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15899 · Foreign Corporation #15,899 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 18 grants
MID-PACK #15,899/49,997
PHOTO-FINISH Changzhou Globe
CPC-FOCUS C07K · 16 areas
INNOV-PAR 41.3/100
CLAIMS-PAR 10.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +300% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Changzhou Globe Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How China’s 41.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.2 pts (25%) Velocity 10.7 pts (26%) Breadth 14.1 pts (34%) Claim depth 6.3 pts (15%)

Qualcomm Incorporated · highest

85
China Medical… · this assignee

41
3D Lighting… · lowest

7

What this shows China's Innovation Score is 41.3/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for China?

Each dot is one of China’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). China’s own 10.4 claims/patent is at or below the 12.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

China vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where China's grants concentrate

China Medical University Hospital is a focused PatentsView assignee: 16 CPC subclasses with 44.4% of grants classified under C07K (Peptides). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2017. By volume, China sits between Changzhou Globe Co., Ltd. and Clover Health.

China's three-year grant acceleration

China Medical University Hospital shows 8 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Changzhou Globe

18
Changzhou Jutal

18
Chapman/Leonard S…

18
Cheer Pack North…

18
Ciphercloud

18
Climax Technology

18
Clinc

18
Clover Health

18
China Medical Uni… ◀

18

What this shows China holds 18 patents at rank #15,924, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near China

By rank, the assignees closest to #15,924 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in China's primary technology class.

China's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

China Medical University Hospital patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	5.6%
2018	1	5.6%
2019	1	5.6%
2020	1	5.6%
2021	3	16.7%
2022	3	16.7%
2023	3	16.7%
2024	2	11.1%
2025partial year	3	16.7%

Which technologies does China Medical University Hospital patent most?

C07K - Peptides 8

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

G06T - Image Data Processing OR Generation, IN General 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

A61B - DIAGNOSIS; SURGERY; Identification 4

G06N - Computing Arrangements Based ON Specific Computational Models 4

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

C07D - Heterocyclic Compounds 1

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

G06F - Electric Digital Data Processing 1

H04N - Pictorial Communication, e.g. Television 1

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 1

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 1

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

China Medical University Hospital's patent record in context - here's where to go next.

China Medical University Hospital's lead technology class is C07K (Peptides), 44.4% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #15,899 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare China Medical University Hospital against Changzhou Globe Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.